CarimuneNanofiltered (CSL Behring AG)
Welcome to the PulseAid listing for the Carimune drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | CSL Behring AG |
| NON-PROPRIETARY NAME: | HUMAN IMMUNOGLOBULIN G |
| SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-02-10 |
| END MARKETING DATE: | 0000-00-00 |
Carimune Nanofiltered PLASMA DERIVATIVE Details:
| Item Description | Carimune Nanofiltered from CSL Behring AG |
| LABELER NAME: | CSL Behring AG |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(g/1) |
| START MARKETING DATE: | 2009-02-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44206-417_a42c1c72-8631-4dba-8bba-2e6a2a701da3 |
| PRODUCT NDC: | 44206-417 |
| APPLICATION NUMBER: | BLA102367 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers:
